We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 20th:
Regional Management Corp. (RM - Free Report) : This diversified consumer finance company has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 1.5% over the last 60 days.
BGC Partners, Inc. : This operates as a brokerage and financial technology company has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 4.8% over the last 60 days.
Green Brick Partners, Inc. (GRBK - Free Report) : This homebuilding and land development company has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 37.4% over the last 60 days.
PennyMac Financial Services, Inc. (PFSI - Free Report) : This company that engages in the mortgage banking and investment management activities has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 42.1% over the last 60 days.
PennyMac Financial Services, Inc. Price and Consensus
PennyMac Financial Services has a price-to-earnings ratio (P/E) of 3.52, compared with 137.20 for the industry. The company possesses a Value Score of A.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Top Ranked Value Stocks to Buy for April 20th
Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 20th:
Regional Management Corp. (RM - Free Report) : This diversified consumer finance company has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 1.5% over the last 60 days.
Regional Management Corp. Price and Consensus
Regional Management Corp. price-consensus-chart | Regional Management Corp. Quote
Regional Management has a price-to-earnings ratio (P/E) of 3.49, compared with 5.80 for the industry. The company possesses a Value Score of A.
Regional Management Corp. PE Ratio (TTM)
Regional Management Corp. pe-ratio-ttm | Regional Management Corp. Quote
BGC Partners, Inc. : This operates as a brokerage and financial technology company has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 4.8% over the last 60 days.
BGC Partners, Inc. Price and Consensus
BGC Partners, Inc. price-consensus-chart | BGC Partners, Inc. Quote
BGC Partners has a price-to-earnings ratio (P/E) of 4.16, compared with 13.60 for the industry. The company possesses a Value Score of A.
BGC Partners, Inc. PE Ratio (TTM)
BGC Partners, Inc. pe-ratio-ttm | BGC Partners, Inc. Quote
Green Brick Partners, Inc. (GRBK - Free Report) : This homebuilding and land development company has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 37.4% over the last 60 days.
Green Brick Partners, Inc. Price and Consensus
Green Brick Partners, Inc. price-consensus-chart | Green Brick Partners, Inc. Quote
Green Brick Partners has a price-to-earnings ratio (P/E) of 4.95, compared with 22.30 for the industry. The company possesses a Value Score of A.
Green Brick Partners, Inc. PE Ratio (TTM)
Green Brick Partners, Inc. pe-ratio-ttm | Green Brick Partners, Inc. Quote
PennyMac Financial Services, Inc. (PFSI - Free Report) : This company that engages in the mortgage banking and investment management activities has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 42.1% over the last 60 days.
PennyMac Financial Services, Inc. Price and Consensus
PennyMac Financial Services, Inc. price-consensus-chart | PennyMac Financial Services, Inc. Quote
PennyMac Financial Services has a price-to-earnings ratio (P/E) of 3.52, compared with 137.20 for the industry. The company possesses a Value Score of A.
PennyMac Financial Services, Inc. PE Ratio (TTM)
PennyMac Financial Services, Inc. pe-ratio-ttm | PennyMac Financial Services, Inc. Quote
See the full list of top ranked stocks here.
Learn more about the Value score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>